Related Experiment Video
Updated: Aug 8, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
Published on: November 2, 2018
Involvement of nuclear factor-kappa B in induction of the interleukin-6 gene by leukemia inhibitory factor
H J Gruss1, M A Brach, F Herrmann
1Department of Internal Medicine I, University of Freiburg Medical Center, Germany.
Insights
Leukemia inhibitory factor (LIF) stimulates interleukin-6 (IL-6) production in human immune cells. This occurs via transcriptional activation of the IL-6 gene, primarily involving the nuclear factor kappa B (NF-κB) pathway.
Area of Science:
- Immunology
- Molecular Biology
- Cellular Biology
Background:
- Leukemia inhibitory factor (LIF) is known to induce interleukin-6 (IL-6) secretion in myeloid cells.
- The precise molecular mechanisms underlying LIF-induced IL-6 production require further elucidation.
Purpose of the Study:
- To investigate the molecular mechanisms by which recombinant human LIF (rhLIF) induces IL-6 gene expression in human mononuclear phagocytes.
- To identify the key transcription factors and regulatory elements involved in LIF-mediated IL-6 gene activation.
Main Methods:
- Analysis of IL-6 transcript levels and gene promoter activity in mononuclear phagocytes treated with rhLIF.
- Deletion analysis of the IL-6 promoter to identify critical regulatory regions.
- Electrophoretic mobility shift assays (EMSAs) to assess transcription factor binding.
- Reporter gene assays using heterologous promoter constructs.
Main Results:
- rhLIF exposure led to increased IL-6 transcript levels and transcriptional activation of the IL-6 gene in mononuclear phagocytes.
- Transcriptional activation was associated with enhanced binding activity of nuclear factor kappa B (NF-κB).
- NF-κB binding sites, but not AP-1 or NF-IL-6 binding sites, were crucial for LIF-induced IL-6 promoter activity.
Conclusions:
- rhLIF induces IL-6 gene expression in human mononuclear phagocytes through transcriptional activation.
- The nuclear factor kappa B (NF-κB) pathway plays a critical role in mediating LIF-induced IL-6 gene expression.
Abstract:
Recent studies have indicated that the leukemia inhibitory factor (LIF) induces secretion of interleukin-6 (IL-6) in myeloid cells. We here show that synthesis of IL-6 by human mononuclear phagocytes exposed to recombinant human (rh) LIF is preceded by an increase of IL-6 transcript levels as a result of transcriptional activation of the IL-6 gene. Analysis of deleted fragments of the IL-6 promoter indicated that transcriptional activation of the IL-6 promoter was associated with enhanced binding activity of the transcription factor nuclear factor (NF)-kappa B. Binding of activation protein (AP)-1 and NF-IL-6, also known to transcriptionally activate the IL-6 promoter, was not inducible by LIF. Furthermore, introduction of the NF-kappa B sequence into a heterologous promoter construct, but not of AP-1- and NF-IL-6-binding sequences, conferred inducibility by LIF to this promoter. Deletion of the NF-kappa B binding site in the IL-6 promoter was associated with loss of inducibility by LIF, lending further support for the notion that the NF-kappa B binding site is crucial for LIF-mediated induction of the IL-6 promoter. Taken together, our results show that rhLIF induces IL-6 gene expression in mononuclear phagocytes through transcriptional gene activation involving NF-kappa B.
More Related Videos
Related Concept Videos
Co-activators and Co-repressors
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Lineage Commitment
General Transcription Factors
The JAK-STAT Signaling Pathway
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

